ISDA

Deposition Date 2017-02-17

Release Date 2017-12-27

Last Version Date 2024-03-27

Entry Detail

PDB ID:

5X5O

Keywords:

TRANSFERASE

Title:

Crystal structure of ZAK in complex with compound D2829

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.87 Å

R-Value Free:

0.22

R-Value Work:

0.18

R-Value Observed:

0.19

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase kinase kinase MLT
Gene (Uniprot):MAP3K20
Chain IDs:A
Chain Length:310
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9NYL2 Pfam ID:PF07714

Ligand Molecules

7Z0

Primary Citation

Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-alpha Motif Kinase (ZAK) Inhibitors.

Chang, Y, Lu, X, Shibu, M.A, Dai, Y.B, Luo, J, Zhang, Y, Li, Y, Zhao, P, Zhang, Z, Xu, Y, Tu, Z.C, Zhang, Q.W, Yun, C.H, Huang, C.Y, Ding, K.Show

J. Med. Chem. 60 5927 5932 (2017)

PMID: 28586211 DOI: 10.1021/acs.jmedchem.7b00572

Abstact

A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class of highly selective ZAK inhibitors. The representative compound 3h strongly inhibits the kinase activity of ZAK with an IC50 of 3.3 nM and dose-dependently suppresses the activation of ZAK downstream signals in vitro and in vivo, while it is significantly less potent for the majority of 403 nonmutated kinases evaluated. Compound 3h also exhibits orally therapeutic effects on cardiac hypertrophy in a spontaneous hypertensive rat model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures